Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-25

Clinical Trial Update: BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating benralizumab's impact on airway dynamics in severe eosinophilic asthma using Functional Respiratory Imaging; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2025-03-25